Christian Doppler Laboratory for Advanced Crystal Engineering Strategies in Drug Development
Laboratory Head: Assoc.-Prof. Doris E. Braun
Commercial Partner: Sandoz GmbH
The CD Laboratory aims to research critical material properties of pharmaceutical excipients and active pharmaceutical ingredients that are crucial for the production, quality and safety of high-quality drugs. Optimising these properties makes it possible to accelerate manufacturing processes and ultimately reduce the costs of essential drug products.
The vast majority of currently available active pharmaceutical ingredients consist of small molecules, which, for reasons of chemical stability, are usually processed in a crystalline state into solid dosage forms such as tablets. However, the structural diversity and, above all, the complexity of drug substances has increased enormously in the last two decades, which inevitably results in a deterioration of critical solid-state properties, such as water solubility.
Targeted optimisation strategies for drug substances are therefore increasingly the focus of modern drug development. Such efforts are largely based on material science approaches such as ‘crystal engineering’. Dozens of crystal forms can be produced from most drugs using sophisticated strategies and methods, and their properties can differ significantly. The challenge is to identify the form(s) with the best properties in terms of physical and chemical stability, solubility, processability, mechanical properties, etc. This is a fundamental prerequisite for the further development of a biologically active substance into a marketable drug.
The design and synthesis of solid structures with the desired properties requires a thorough understanding of the principles of molecular interaction and a broad research methodology. The topic encompasses a wide range of solid-state phenomena and the spectrum of solid forms ranges from crystals consisting of only one type of molecule with different packing arrangements (polymorphism) to complex multi-component crystals (co-crystals) and non-crystalline (amorphous) solids.
The overarching goal of this CD Laboratory is to explore and establish an understanding of the interplay between molecular features and supramolecular properties that influence the chemical and physical stability, processability, and biological efficacy of drugs. This is achieved by combining a variety of computational and experimental methods and processes.
In addition to optimising the material properties of new active ingredients, research also includes innovative, formulation-related topics. The CD Laboratory focuses on a comprehensive understanding of the formation of solid forms, their stability and production-relevant properties. This enables better predictability of the solid forms. Directives for customised experimental and virtual methods for finding new solid phases, as well as new strategies for stabilising metastable solid forms, are also being developed. This requires a sound knowledge of the molecular interactions between the active pharmaceutical ingredient and the excipients (co-formers), which are obtained from experimental or computer-generated structures. This also allows the prediction of process-relevant properties of drugs, which are essential for drug manufacturing processes.
Jiang, Y., et al. Decoding Hierarchical Crystal Packing in Phenprocoumon and Related 4-Hydroxycoumarins. Crystal Growth & Design, 2026. accepted 23.10.2026.
Dyba, A.J., et al., Solvates Under Stress: Mapping Stability and Desolvation Pathways in Daprodustat. CrystEngComm, 2026.
Dyba, A.J., et al., Exploring Structural Diversity and Similarity in Daprodustat: Polymorphs, Solvates, Crystal Structures, and Crystal Morphology. Journal of Molecular Structure, 2027. 1381: p. 147640.
Schinke, J., et al., Tovorafenib Solvates: Insights into Structure, Stability, and Crystallization Behavior. Journal of Molecular Structure, 2027. 1380: p. 147335.
Wood, W.P., et al., BEST-CSP Benchmark Study of Polymorphs I and II of Sulfamerazine and the Perils of Polytype Polymorphs. Crystal Growth & Design, 2026. 26(1): p. 476–493.
Reumayr, L.I., V. Kahlenberg, and D.E. Braun, Exploring sulfathiourea solvate structures: A combined experimental and computational study on crystal forms, desolvation, and stability. Journal of Molecular Structure, 2025. 1336: p. 142124.
Pellegrini, P., et al., From Structure to Stability: Exploring the Solid-State Forms of a Novel First-In-Class PPAR Agonist (Elafibranor). Crystal Growth & Design, 2025. 25(16): p. 6892–6907.
Gelbrich, T., K. Sarsuns, and D.E. Braun, The disordered structure of sparsentan: energy calculations for competing chain conformations. Acta Crystallographica Section C, 2025. 81(9): p. 530–538.
Shtukenberg, A.G., et al., Suppression of Disorder in Benzamide and Thiobenzamide Crystals by Fluorine Substitution. Crystal Growth & Design, 2024. 24(12): p. 5276–5284.
Braun, D.E., M. Stefinovic, and U.J. Griesser, Structural Diversity and Stability of Hexamorphic Mavacamten: Experimental and Computational Insights. Crystal Growth & Design, 2024. 24(20): p. 8381–8396.
Petrick, T.L., et al., Unraveling the Solid-State Complexity of Pirtobrutinib: Polymorphs, Solvates, Hydrates, and Their Transformation Pathways. Journal of Molecular Structure, 2025.
Petrick, T.L., A. Hubmann, and D.E. Braun, Caprolactam Cocrystals: Bridging Virtual Screening to Experimental Solid-State Forms and Stability. Crystal Growth & Design, 2025. 25(8): p. 2657–2673.
Lässer, J. and D.E. Braun, Exploring Coformer Substitution in Cocrystallization: Griseofulvin and Phenol Derivatives. Crystal Growth & Design, 2025. 25(5): p. 1688–1707.
Lectures (Assoc.-Prof. Doris E. Braun)
Structural Exploration of Multi-Component Systems: Complementary Experimental and Computational Insights at the 18th European Powder Diffraction Conference (EPDIC18), Padua / Padova, 01.09.2024.
Navigating Solid-State Complexity in Pharmaceuticals: Experimental and Virtual Approaches at the Crystal Engineering Gordon Research Conference – Desing, Assembly, and Function, Newry, 24.06.2026.
From Molecules to Materials: Exploring Polymorphs, Solvates, Salts, and Cocrystals at the ACCORD Interdisciplinary Conference on Drug Sciences 2026 (ACCORD 2026), Warsaw, 29.05.2026.
Hybrid Approaches in Solid Form Design: Virtual Screening and Experimental Validation at the 13th Bologna's convention on crystal forms (CF@Bo n.13), Bologna, 07.09.2025.
Impact of Coformer Substitution on the Formation and Polymorphism of Pharmaceutical Cocrystals at the 35th European Crystallographic Meeting (ECM35), Poznan, 28.08.2025
Tuning Cocrystallization: The Impact of Coformer Substitution on Metronidazole and Griseofulvin Cocrystals at the Organic Solid-State Symposium (BOSSs), 01.04.2025 (Online).
Streamlining Pharmaceutical Molecule Cocrystallization at the 15th International Workshop on Crystal Growth of Organic Materials (CGOM15), Phuket, 25.07.2024.
Streamlining cocrystal discovery at the ACS Spring Meeting 2024, New Orleans, 21.03.2024.
Crystal Structure Prediction - a computational approach to polymorphism at the Università di Bologna / University of Bologna / Universität Bologna, Bologna, 06.12.2024 (online).
Exploring Pharmaceutical Cocrystals: Bridging Experiment and Theory at the Karl-Franzens-Universität Graz, Graz, 26.01.2024.
Predictive Tools and Techniques in Pharmaceutical Cocrystal Design at the Thermo Fisher, Linz, 11.06.2024
Poster presentations
Pellegrini, Pascal. Co-AutorInnen: Gelbrich, Thomas; Stefinovic, Marijan; Nerdinger, Sven; Braun, Doris E. - The solid-state landscape of mirdametinib at the BEST-CSP Workshop – From molecules to materials: 3rd workshop on benchmarking solid state properties, Lisbon 16.7.2026.
Dyba, Aleksandra J. Co-AutorInnen: Gelbrich, Thomas; Stefinovic, Marijan; Nerdinger, Sven; Braun, Doris E.: Stressing Solvates: Stability and Desolvation Pathways of Daprodustat at the 55th Annual BACG Conference (BACG2026; British Association for Crystal Growth), Manchester, 30.06.2026.
Dyba, Aleksandra J. Co-AutorInnen: Gelbrich, Thomas; Stefinovic, Marijan; Nerdinger, Sven; Braun, Doris E.: A Tangled Web of Solvates: Unravelling the Solid-State Forms of Daprodustat at the BEST-CSP Workshop – From molecules to materials: 2nd workshop on benchmarking solid state properties, Bologna, 10.09.2025.
Contini, Laura Co-AutorInnen: Jiang, Yihua; Leyssens, Tom; Braun, Doris E.; Grepioni Fabrizia: Phenylpiracetam: Solid Solutions and Attempts at Chiral Resolution at the 13th Bologna's convention on crystal forms (CF@Bo n.13), Bologna, 07.09.2025.
Fedrizzi, Alexander Co-AutorInnen: Gelbrich, Thomas; Griesser, Ulrich J.; Braun, Doris E.: Mapping the polymorphic landscape of cyclopentobarbital at the 13th Bologna's convention on crystal forms (CF@Bo n.13), Bologna, 07.09.2025.
Jiang, Yihua; Contini, Laura Co-AutorInnen: Braun, Doris; Leyssens, Tom; Grepioni, Fabrizia: Exploring solid-state landscapes: advances in pharmaceutical polymorphism of phenprocoumon at the 13th Bologna's convention on crystal forms (CF@Bo n.13), Bologna, 07.09.2025.
Pellegrini, Pascal Co-AutorInnen: Gelbrich, Thomas; Stefinovic, Marijan; Nerdinger, Sven; Braun, Doris E: From Molecules to Materials: How Packing and Interactions Define Solid-State Stability of Elafibranor at the 13th Bologna's convention on crystal forms (CF@Bo n.13), Bologna, 07.09.2025.
Wood, William P. Co-AutorInnen: Price, Sarah L.; Salvalaglio, Matteo; Braun, Doris E.; Bučar, Dejan-Krešimir; Guo, Rui; Bhardwaj, Rajni M.: From Prediction to Attempted Realisation: Mapping the Polymorph Landscape of Sulfamerazine and Sulfadiazine at the 13th Bologna's convention on crystal forms (CF@Bo n.13), Bologna, 07.09.2025.
Dyba, Aleksandra J. Co-AutorInnen: Kahlenberg, Volker; Braun, Doris E.: Navigating the metronidazole solid-state landscape – Screening, properties, and structural features at the FunMat Retreat 2025, Rum, 23.05.2025.
Gelbrich, Thomas Co-AutorInnen: Braun, Doris E.; Griesser, Ulrich J.: 5-Monosubstituted Barbiturates: Classification of H-bonded Structures and Packing Relationships at the FunMat Retreat 2025, Rum, 23.05.2025.
Dyba, Aleksandra Co-AutorInnen: Braun, Doris E.: Which metronidazole cocrystals will (not) form? Experimental and computational approaches at the BEST-CSP Workshop – From molecules to materials: 1st workshop on benchmarking solid state properties, Warschau, 11.09.2024.
Wood, William P. Co-AutorInnen: Price, Sarah L.; Braun, Doris E.; Bučar D.-K.: Exploring the Polymorphism of Sulfadiazine and Sulfamerazine through Crystal Structure Prediction at the BEST-CSP Workshop – From molecules to materials: 1st workshop on benchmarking solid state properties, Warschau, 11.09.2024
Contact
Institute of Pharmacy, Pharmaceutical Technology
University of Innsbruck
Innrain 52c, 6020 Innsbruck
Austria
Tel.: +43 512 507 58650















